NCT04345419已完成2 期
Remdesivir in COVID-19 Treatment: A Randomised Trial
适应症
干预措施
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 200
- 试验地点
- 1
- 主要终点
- Number of patients with improvement or mortality
研究概览
简要总结
COVID 19 treatment using Remedesvir.
详细描述
COVID 19 treatment using Remedesvir. Is this drug effective?
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Participant)
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •COVID 19 patients
排除标准
- •allergy or contraindication to the drug
研究组 & 干预措施
Remdesivir
Experimental
Remdesivir with standard of care treatment standard of care treatment
干预措施: Remdesivir (Drug)
Remdesivir
Experimental
Remdesivir with standard of care treatment standard of care treatment
干预措施: Standard of care treatment (Other)
Standard of care
Placebo Comparator
Standard of care treatment alone.
干预措施: Standard of care treatment (Other)
结局指标
主要结局
Number of patients with improvement or mortality
时间窗: 6 months
the estimated number of patients with improvement or mortality
次要结局
未报告次要终点
研究者
Sherief Abd-Elsalam
assistant professor of tropical medicine and infectious diseases
Tanta University
研究点 (1)
Loading locations...
相似试验
已完成
3 期
Remdesivir Efficacy In Management Of COVID-19 PatientsCovid19NCT04853901Ain Shams University77
尚未招募
不适用
A retrospective analysis to study the Effectiveness and Safety profile of Remdesivir therapy in patients who diagnosed with COVID-19CTRI/2021/01/030433Dr Vishal Shanbhag
已完成
3 期
Remdesivir for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)Covid19NCT06729593National Institute of Allergy and Infectious Diseases (NIAID)87
终止
2 期
Clinical Trials to Assess Safety and Efficacy of DWRX2003 Combination With Remdesivir in Moderate to Severe COVID-19 Patients.COVID-19NCT05226533Daewoong Pharmaceutical Co. LTD.1
已完成
不适用
Remdesivir effect in the treatment of coronaCTRI/2020/10/028657Department of pharmacology1,193